Role of Omega-DEK in Childhood Apraxia of Speech | MicrobiomeTrials← Back to trialsNCT07216001
Role of Omega-DEK in Childhood Apraxia of Speech
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-11Est. Completion: 2027-12
Enrollment target: 34 participants Locations- Children's Healthcare of Atlanta, Atlanta, Georgia, United States
- Marcus Autism Center, Atlanta, Georgia, United States
Other microbiome trials you might be interested in
Childhood Apraxia of Speech
Childhood apraxia of speech (CAS) is a complex motor speech disorder that significantly limits a child's ability to comm…
Multiple LocationsEst. completion Sep 1, 2030
Childhood Apraxia of Speech
This study will investigate the feasibility of applying the Rapid Syllable Transition Treatment (ReST) protocol in child…
Florianópolis, BrazilEst. completion Oct 2027